News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Ricardo Ghelman, MD, PhD

Articles by Ricardo Ghelman, MD, PhD

Cancer-Related Fatigue Outcome Measures in Integrative Oncology: Evidence for Practice and Research Recommendations

ByDanielle Gentile, PhD,Dori Beeler, PhD,Xin Shelley Wang, MD, MPH,Eran Ben-Ayre, MD,Suzanna Maria Zick, ND, MPH,Ting Bao, MD, DABMA, MS,Linda E. Carlson, PhD,Ricardo Ghelman, MD, PhD,Viraj A. Master, MD, PhD,Debu Tripathy, MD,W. Iris Zhi, MD, PhD

May 16th 2022

This review article written by Danielle Gentile, PhD, et al, reviews the management of cancer-related fatigue in integrative oncology.

Latest Updated Articles

Cancer-Related Fatigue Outcome Measures in Integrative Oncology: Evidence for Practice and Research Recommendations
Published: May 16th 2022 | Updated:

Trending on CancerNetwork

FDA Approves Belantamab Mafodotin in R/R Multiple Myeloma

FDA Grants Fast Track Designation to MT-125 in Glioblastoma

HDP-101 Receives FDA Fast Track Designation in Multiple Myeloma

FDA Accepts NDA for New Nilotinib Formulation in CML

FDA Grants Priority Review to Enfortumab Vedotin Combo in MIBC Subset

© 2025 MJH Life Sciences^®

All rights reserved.